头颈部肿瘤临床实践指南（2017 年）
SEOM clinical guideline in nasopharynx cancer (2017).
机构信息
Servicio de Oncología Médica, Hospital La Fe de Valencia, Valencia, Spain.
Servicio de Oncología Médica - IIBSP, Hospital Sant Pau, Barcelona, Spain.
出版信息
Clin Transl Oncol. 2018 Jan;20(1):84-88. doi: 10.1007/s12094-017-1777-0. Epub 2017 Nov 2.
Abstract
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
摘要
鼻咽癌（NPC）在生物学、流行病学、组织学、自然史和对治疗的反应方面与头颈部的其他癌症不同。放射治疗是治疗非扩散性疾病的重要组成部分，联合化疗可提高生存率。对于转移性疾病阶段，治疗需要基于铂类/吉西他滨的化疗，患者可能实现较长的生存时间。
相似文献
1
SEOM clinical guideline in nasopharynx cancer (2017).头颈部肿瘤临床实践指南（2017 年）
Clin Transl Oncol. 2018 Jan;20(1):84-88. doi: 10.1007/s12094-017-1777-0. Epub 2017 Nov 2.
2
SEOM-TTCC clinical guideline in nasopharynx cancer (2021).SEOM-TTCC 鼻咽癌临床指南（2021）。
Clin Transl Oncol. 2022 Apr;24(4):670-680. doi: 10.1007/s12094-022-02814-x. Epub 2022 Mar 18.
3
SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013.2013 年 SEOM 鼻咽癌治疗临床指南。
Clin Transl Oncol. 2013 Dec;15(12):1025-9. doi: 10.1007/s12094-013-1094-1. Epub 2013 Aug 27.
4
ACR Appropriateness criteria® for nasopharyngeal carcinoma.美国放射学会（ACR）鼻咽癌适宜性标准®
Head Neck. 2016 Jul;38(7):979-86. doi: 10.1002/hed.24423. Epub 2016 Apr 30.
5
With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control study.局部晚期复发性鼻咽癌再程放疗与否：一项病例对照研究
BMC Cancer. 2016 Oct 7;16(1):774. doi: 10.1186/s12885-016-2803-2.
6
High expression of Ki-67 acts a poor prognosis indicator in locally advanced nasopharyngeal carcinoma.Ki-67的高表达是局部晚期鼻咽癌预后不良的一个指标。
Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):390-396. doi: 10.1016/j.bbrc.2017.09.118. Epub 2017 Sep 22.
7
Carcinoma of the nasopharynx.鼻咽癌
Semin Ultrasound CT MR. 1998 Dec;19(6):449-62. doi: 10.1016/s0887-2171(98)90048-8.
8
Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.洛铂联合5-氟尿嘧啶作为一线诱导化疗随后进行洛铂-放疗用于局部晚期鼻咽癌的安全性和有效性：一项前瞻性II期试验的初步结果
BMC Cancer. 2017 Feb 15;17(1):134. doi: 10.1186/s12885-017-3080-4.
9
Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines.鼻咽癌：英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S97-S103. doi: 10.1017/S0022215116000517.
10
Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system.使用临床和生化评分系统对转移性鼻咽癌患者进行预后分层
J Cancer Res Clin Oncol. 2017 Dec;143(12):2563-2570. doi: 10.1007/s00432-017-2496-1. Epub 2017 Aug 28.
引用本文的文献
1
Pre-treatment and post-treatment nasopharyngeal carcinoma imaging: imaging updates, pearls and pitfalls.鼻咽癌治疗前和治疗后的影像学检查：影像学进展、要点与陷阱
Neuroradiology. 2025 Apr;67(4):1023-1047. doi: 10.1007/s00234-025-03596-z. Epub 2025 Apr 11.
2
Efficacy analysis of endovascular treatment for ruptured internal carotid artery pseudoaneurysm hemorrhage in patients with nasopharyngeal carcinoma after radiotherapy.鼻咽癌放疗后颈内动脉假性动脉瘤破裂出血的血管内治疗疗效分析
Front Surg. 2024 Aug 20;11:1451570. doi: 10.3389/fsurg.2024.1451570. eCollection 2024.
3
Multimodal treatment according to the NPC-GPOH trials in adult patients with nasopharyngeal cancer-Analysis based on a single-center experience.多模态治疗成人鼻咽癌 NPC-GPOH 试验-基于单中心经验的分析。
Cancer Rep (Hoboken). 2024 Aug;7(8):e2111. doi: 10.1002/cnr2.2111.
4
Assessing the methodological strengths and limitations of the Spanish Society of Medical Oncology (SEOM) guidelines: a critical appraisal using AGREE II and AGREE-REX tool.评估西班牙肿瘤内科学会（SEOM）指南的方法学优势和局限性：使用 AGREE II 和 AGREE-REX 工具进行批判性评估。
Clin Transl Oncol. 2024 Jan;26(1):85-97. doi: 10.1007/s12094-023-03219-0. Epub 2023 Jun 27.
5
Lifestyle, Epstein-Barr virus infection, and other factors could impede nasopharyngeal cancer survivorship: a five-year cross-sectional study in North Eastern India.生活方式、爱泼斯坦-巴尔病毒感染及其他因素可能阻碍鼻咽癌患者的生存：印度东北部的一项为期五年的横断面研究。
Virusdisease. 2022 Dec;33(4):371-382. doi: 10.1007/s13337-022-00789-5. Epub 2022 Nov 8.
6
Epstein-Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments.EB 病毒（EBV）上皮相关恶性肿瘤：探索病理学和当前治疗方法。
Int J Mol Sci. 2022 Nov 19;23(22):14389. doi: 10.3390/ijms232214389.
7
The Use of Traditional Chinese Medicine in Patients with Oral, Oropharynx, Nasopharynx, and Hypopharynx Cancers: A Retrospective Longitudinal Cohort Study in Taiwan.台湾地区口腔、口咽、鼻咽和下咽癌患者使用中医药的回顾性纵向队列研究。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221132790. doi: 10.1177/15347354221132790.
8
Prognostic Value of a Serum Panel of Inflammatory Factors in Non-Metastatic Nasopharyngeal Carcinoma Patients Undergoing Radical Radiotherapy with Adjuvant Chemotherapy.血清炎症因子检测对接受根治性放疗联合辅助化疗的非转移性鼻咽癌患者的预后价值
Cancer Manag Res. 2022 Sep 16;14:2763-2772. doi: 10.2147/CMAR.S371922. eCollection 2022.
9
MRI detection of suspected nasopharyngeal carcinoma: a systematic review and meta-analysis.磁共振成像检测疑似鼻咽癌：系统评价和荟萃分析。
Neuroradiology. 2022 Aug;64(8):1471-1481. doi: 10.1007/s00234-022-02941-w. Epub 2022 Apr 30.
10
Biopsy of cervical lymph node does not impact the survival of nasopharyngeal carcinoma.颈淋巴结活检不影响鼻咽癌的生存。
Cancer Med. 2021 Oct;10(19):6687-6696. doi: 10.1002/cam4.4204. Epub 2021 Aug 12.
本文引用的文献
1
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.局部晚期鼻咽癌的最佳治疗方法是什么？一项个体患者数据网络荟萃分析。
J Clin Oncol. 2017 Feb 10;35(5):498-505. doi: 10.1200/JCO.2016.67.4119. Epub 2016 Dec 5.
2
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.诱导化疗加同期放化疗对比单纯同期放化疗治疗局部晚期鼻咽癌：一项 3 期、多中心、随机对照临床试验。
Lancet Oncol. 2016 Nov;17(11):1509-1520. doi: 10.1016/S1470-2045(16)30410-7. Epub 2016 Sep 27.
3
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.吉西他滨联合顺铂对比氟尿嘧啶联合顺铂治疗复发或转移性鼻咽癌的多中心、随机、开放标签、III 期临床试验。
Lancet. 2016 Oct 15;388(10054):1883-1892. doi: 10.1016/S0140-6736(16)31388-5. Epub 2016 Aug 23.
4
Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.鼻咽癌治疗的演进——调强放射治疗时代的成功与挫折
Radiother Oncol. 2014 Mar;110(3):377-84. doi: 10.1016/j.radonc.2014.02.003. Epub 2014 Mar 11.
5
Salvage treatment for locally recurrent nasopharyngeal carcinoma (NPC).局部复发鼻咽癌的挽救性治疗。
Am J Clin Oncol. 2014 Aug;37(4):327-31. doi: 10.1097/COC.0b013e318277d804.
6
Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.鼻咽癌：欧洲鼻咽喉科学会（EHNS）-欧洲肿瘤内科学会（ESMO）-欧洲放射肿瘤学会（ESTRO）诊断、治疗及随访临床实践指南
Ann Oncol. 2012 Oct;23 Suppl 7:vii83-5. doi: 10.1093/annonc/mds266.
7
Impact of Radiotherapy Dose on Dentition Breakdown in Head and Neck Cancer Patients.放疗剂量对头颈部癌症患者牙列破坏的影响
Pract Radiat Oncol. 2011;1(3):142-148. doi: 10.1016/j.prro.2011.03.003.
8
Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.随机对照试验：放疗联合同期辅助化疗对比单纯放疗用于局部晚期鼻咽癌。
J Natl Cancer Inst. 2010 Aug 4;102(15):1188-98. doi: 10.1093/jnci/djq258. Epub 2010 Jul 15.
9
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.新辅助化疗后序贯同步放化疗治疗局部晚期鼻咽癌。
Chin J Cancer. 2010 May;29(5):551-5. doi: 10.5732/cjc.009.10518.
10
Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment.营养影响症状：治疗前头颈部癌症患者饮食摄入减少、体重减轻和功能能力下降的关键决定因素。
Head Neck. 2010 Mar;32(3):290-300. doi: 10.1002/hed.21174.
Zotero 插件